GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Pharmaceutical Group Co Ltd (SHSE:600664) » Definitions » Market Cap

Harbin Pharmaceutical Group Co (SHSE:600664) Market Cap : ¥8,513 Mil (As of Apr. 17, 2025)


View and export this data going back to 1993. Start your Free Trial

What is Harbin Pharmaceutical Group Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Harbin Pharmaceutical Group Co's share price for the quarter that ended in Sep. 2024 was ¥3.75. Harbin Pharmaceutical Group Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 2,519 Mil. Therefore, Harbin Pharmaceutical Group Co's market cap for the quarter that ended in Sep. 2024 was ¥9,444 Mil.

Harbin Pharmaceutical Group Co's quarterly market cap declined from Mar. 2024 (¥7,438 Mil) to Jun. 2024 (¥6,656 Mil) but then increased from Jun. 2024 (¥6,656 Mil) to Sep. 2024 (¥9,444 Mil).

Harbin Pharmaceutical Group Co's annual market cap declined from Dec. 2021 (¥8,940 Mil) to Dec. 2022 (¥7,603 Mil) but then increased from Dec. 2022 (¥7,603 Mil) to Dec. 2023 (¥8,446 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Harbin Pharmaceutical Group Co's Enterprise Value for Today is ¥7,920 Mil.


Harbin Pharmaceutical Group Co Market Cap Historical Data

The historical data trend for Harbin Pharmaceutical Group Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Pharmaceutical Group Co Market Cap Chart

Harbin Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,501.60 7,997.19 8,940.23 7,602.89 8,446.28

Harbin Pharmaceutical Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,747.55 8,446.28 7,437.77 6,656.18 9,444.41

Competitive Comparison of Harbin Pharmaceutical Group Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Pharmaceutical Group Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harbin Pharmaceutical Group Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Pharmaceutical Group Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Harbin Pharmaceutical Group Co's Market Cap falls into.


;
;

Harbin Pharmaceutical Group Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Harbin Pharmaceutical Group Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥3.35*2521.279
=¥8,446

Harbin Pharmaceutical Group Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=¥3.75*2518.510
=¥9,444

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Harbin Pharmaceutical Group Co  (SHSE:600664) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Harbin Pharmaceutical Group Co Market Cap Related Terms

Thank you for viewing the detailed overview of Harbin Pharmaceutical Group Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Harbin Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
Xi'an Street West, People 's Development Zone Baoan Road South, Heilongjiang Province, Harbin, CHN, 150018
Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.
Executives
Liu Bo senior management
Xia Ji Cheng senior management
Qiu Fang Ju Supervisors
Li Bang Dong senior management
Jiang Hai Tao senior management
Meng Xiao Dong senior management
Lin Guo Ren senior management
Wang Hai Sheng senior management
Xu Hai Ying Directors, senior managers
Liang Chen senior management
Wang Peng Hao senior management
Xiao Qiang senior management
Bian Ke Supervisors
Zhou Xing senior management
Wei Shuang Ying senior management

Harbin Pharmaceutical Group Co Headlines

No Headlines